Top Markets
#1 Zora Zora +33.04%
#2 AI XOVIA AI XOVIA +26.43%
#3 0G 0G +20.34%
#4 Full Moon Full Moon +18.72%
#5 Helium Helium +16.76%
#6 Notcoin Notcoin +15.68%
#7 Axelar Axelar +12.89%
#8 Wrapped NXM Wrapped NXM +12.33%
#9 rsERG rsERG +12.19%
#10 Yield Basis Yield Basis +10.82%
Coin of the day
Zora Zora
Settings
Language
ENGLISH
Currency
USD
Theme
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Rank in Stocks #12786
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Share Price
$5.87
Last synced: 2022-11-08
Market Cap
$550.43M
Change (1 day)
1.03%
Change (1 year)
0.00%
Country
US
Trade Silverback Therapeutics, Inc. (SBTX)

Category

Healthcare
Number of shares outstanding for Silverback Therapeutics, Inc. (SBTX)
Number of shares outstanding as of August 2026: 0
According to Silverback Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Silverback Therapeutics, Inc. (SBTX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH